In addition to the $1,500 grand prize, called the Lea Rudee Outstanding Poster Award, judges selected one student presenter from each of the Jacobs School’s six academic departments to receive a $750 ...

The abstracts are scheduled to be posted to the AACR Online Program Planner at 4:30 PM ET on Tuesday, March 25. About AACR The American Association for Cancer Research (AACR) is the first and ...

CONCORD, Mass.–(BUSINESS WIRE)–ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract will be ...

IBSRELA (tenapanor) is a locally acting inhibitor of the sodium/hydrogen exchanger 3 (NHE3), an antiporter expressed on the apical surface of the small intestine and colon primarily responsible ...

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference ... which can enhance visibility and credibility within the biotechnology community. The updated results of the Phase ...

April 23, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company ... has been accepted as a late-breaking poster presentation at the European Association for ...

Refining and finalizing an AI slide deck I liked how it created a "storyboard" presentation, but some of the imagery was off. For example, it had photos of Steve Jobs and the Bucket List movie ...

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal ...

The abstract submission deadline is April 21, 2025. In addition to oral presentation awards, competitively selected research posters will be judged during the conference in Poster Presentation ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at the International Society for Heart and Lung ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...